Concord Drugs Limited (CONCORD.BO)

INR 36.45

(-2.72%)

Market Cap (In INR)

318.7 Million

Revenue (In INR)

449.24 Million

Net Income (In INR)

4.72 Million

Avg. Volume

6638.00

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
11.68-37.98
PE
-
EPS
-
Beta Value
0.7860586
ISIN
INE858L01010
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
-
Employee Count
-
Website
http://www.concorddrugs.in
Ipo Date
2015-02-23
Details
Concord Drugs Ltd. engages in the provision of pharmaceutical formulations. Its products include ready to fill pellets, mup's tissue bio adhesive, injectables, oral solid dosages, oral solid dosages, and liquid orals. The company was founded on April 24, 1995 and is headquartered in Hyderabad, India.